R1 RCM Inc. (RCM)
- Previous Close
14.17 - Open
14.15 - Bid 14.16 x 500
- Ask 14.18 x 600
- Day's Range
14.15 - 14.18 - 52 Week Range
8.87 - 15.38 - Volume
1,312,114 - Avg. Volume
5,098,196 - Market Cap (intraday)
5.981B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
-- - EPS (TTM)
-0.09 - Earnings Date Nov 2, 2024 - Nov 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
14.54
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah.
www.r1rcm.com29,400
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RCM
View MoreResearch Reports: RCM
View MorePerformance Overview: RCM
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RCM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RCM
View MoreValuation Measures
Market Cap
5.98B
Enterprise Value
8.19B
Trailing P/E
--
Forward P/E
51.55
PEG Ratio (5yr expected)
2.06
Price/Sales (ttm)
2.61
Price/Book (mrq)
2.12
Enterprise Value/Revenue
3.44
Enterprise Value/EBITDA
19.02
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.68%
Return on Assets (ttm)
2.90%
Return on Equity (ttm)
-1.44%
Revenue (ttm)
2.38B
Net Income Avi to Common (ttm)
-40M
Diluted EPS (ttm)
-0.09
Balance Sheet and Cash Flow
Total Cash (mrq)
172.6M
Total Debt/Equity (mrq)
84.01%
Levered Free Cash Flow (ttm)
268.68M